NCT01425853View on ClinicalTrials.gov

Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Knee Osteoarthritis
Interventions
DRUG

Chondroitin/Glucosamine (Droglican)

Experimental

DRUG

Celecoxib

Active comparator

Trial Locations (1)

28046

Hospital Universitario La Paz, Madrid

Sponsors

Lead Sponsor

Bioiberica
All Listed Sponsors
lead

Bioiberica

INDUSTRY

NCT01425853 - Study on Efficacy and Safety of Chondroitin Sulfate + Glucosamine Hydrochloride Versus Celecoxib in Knee Osteoarthritis | Biotech Hunter | Biotech Hunter